A director converts a stock grant and holds 141,585 Solid Biosciences (SLDB) shares directly.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Solid Biosciences director Ian F. Smith converted 3,440 restricted stock units into 3,440 common shares on October 2, 2026, increasing his direct holdings to 141,585 shares. The restricted stock units were granted on January 2, 2026, and vested in equal quarterly installments over 12 months. This transaction, detailed in a Form 4 SEC filing, represents a neutral filing impact and sentiment according to Rhea-AI.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.